BPTH— BIO-PATH HOLDINGS, INC.

$2M mkt cap

Metric	FY2024	FY2023	FY2022	FY2021
Research and development	$7.3M-37.2%	$11.6M+26.7%	$9.2M+55.1%	$5.9M
General and administrative	$4.7M+10.9%	$4.2M-10.6%	$4.7M+4.5%	$4.5M
Total operating expenses	$12.0M-24.3%	$15.8M+14.0%	$13.9M+33.1%	$10.4M
Net operating loss	-$12.0M+24.3%	-$15.8M-14.0%	-$13.9M-33.1%	-$10.4M
Other income	—	—	—	—
Change in fair value of warrant liability	$2.1M+869.0%	-$271K	—	—
Interest income	$14K-61.1%	$36K+9.1%	$33K+1000.0%	$3K
Total other income	$2.1M+992.8%	-$235K-812.1%	$33K+1000.0%	$3K
Net loss	-$9.9M+38.5%	-$16.1M-15.9%	-$13.9M-32.8%	-$10.4M
Net loss per share, basic	-$4120.00+87.7%	-$33630.00+11.8%	-$38120.00-2359.4%	-$1550.00
Weighted average number of common shares outstanding, basic	2.4M+402.3%	478K+31.3%	364K-94.6%	6.7M
Net loss per share, diluted	-$4120.00+87.7%	-$33630.00+11.8%	-$38120.00-2359.4%	-$1550.00
Weighted average number of common shares outstanding, diluted	2.4M+402.3%	478K+31.3%	364K-94.6%	6.7M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.